Funded Tech Companies
Autoimmunity BioSolutions
Operating out of League City, Autoimmunity BioSolutions raised its funding from Alexandria Venture Investments, Independent Capital Partners and Eos Bioinnovation.
Company Overview
Company Name
Autoimmunity BioSolutions
Company Status
Private & Independent
Industry
Life Sciences
Funding Rounds
Total Funding
Contact Information
Mailing Address
1455 Louisiana Avenue 4207
League City, TX 77573
USA
League City, TX 77573
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
Next-Generation, Immuno-Corrective Therapy for Treatment of Autoimmune Diseases by Targeting a Novel, Fundamental Autoimmune Pathway Driven by Upregulation of the Soluble Interleukin 7 Receptor (sIL7R). Autoimmunity BioSolutions (ABS) is developing a next-generation, immuno-corrective therapy to restore normal immune function in a genetically-defined subpopulation of autoimmune disease patients in which the autoimmune pathology is driven by a SNP that enhances the expression of sIL7R.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
11/28/2024
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Eugene Williams
Chief Scientific Officer
Gaddiel Galarza-Muñoz
Company Investors
- Alexandria Venture Investments
- Independent Capital Partners
- Eos Bioinnovation
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs